North America Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service (Assays & Kits, Instruments & Analyzers and Software & Services), By End User, By Technology, By Application, By Country and Growth Forecast, 2023 - 2030
The North America Point of Care Molecular Diagnostics Market would witness market growth of 9.5% CAGR during the forecast period (2023-2030).
The healthcare system in the United States is sophisticated and well-organized. Additionally, the system supports R&D. The regulations promote foreign companies' entry into the US and the North American market. A large increase has also aided the growth of the market in new introductions. Molecular diagnostics has led the response to the COVID-19 pandemic. for instance, a study titled "Point-of-Care PCR Assays for COVID-19 Detection" published in the US National Library of Medicine claimed that reverse transcriptase-polymerase chain reaction (RT-PCR) and the quantitative variant (qRT-PCR) were considered the gold standard for COVID-19 diagnosis. However, there are several restrictions on molecular diagnostic technology.
As an instance, a research paper titled "Molecular diagnostic technologies for COVID-19: Limitations and challenges," published in the US National Library of Medicine in November 2020, explained that modern molecular diagnostics are not intended for point-of-care diagnosis of COVID-19 however, offer a core diagnostic solution for carrying out a large number of tests in a reasonable amount of time. Therefore, a precise diagnosis is essential to stop the spread of the illness. Such investigations deepen our understanding of the uses and constraints of molecular diagnostic tools. Product introductions are another component in the market's expansion.
The United States has the highest rate of cancer prevalence. The American Cancer Society estimates that 608,570 cancer deaths and 1,898,160 new cancer cases will be diagnosed in the United States in 2021. The same source also said that 90,222 cancer-related fatalities and 195,499 new cancer cases are anticipated in Mexico in 2020. The market is anticipated to grow even more due to the region's strong demand being matched by companies.
The US market dominated the North America Point of Care Molecular Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,103.2 million by 2030. The Canada market is showcasing a CAGR of 11.9% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 11% during (2023 - 2030).
Based on Product & Service, the market is segmented into Assays & Kits, Instruments & Analyzers and Software & Services. Based on End User, the market is segmented into Physicians Offices, Hospitals & ICUs, Research Institutes and Others. Based on by Technology, the market is segmented into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others. Based on Application, the market is segmented into Respiratory Diseases, Hospital-acquired Infections, Sexually Transmitted Diseases, Cancer, Hepatitis, Gastrointestinal Disorders and Others.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation
Scope of the Study
Market Segments covered in the Report:
By Product & Service
- Assays & Kits
- Instruments & Analyzers
- Software & Services Surveillance & Monitoring
- Physicians Offices
- Hospitals & ICUs
- Research Institutes
- Others
- RT-PCR
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
- Respiratory Diseases
- Hospital-acquired Infections
- Sexually Transmitted Diseases
- Cancer
- Hepatitis
- Gastrointestinal Disorders
- Others
- US
- Canada
- Mexico
- Rest of North America
- Abbott Laboratories
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- BioMerieux S.A.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Nova Biomedical Corporation
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Point of Care Molecular Diagnostics Market, by Product & Service
- 1.4.2 North America Point of Care Molecular Diagnostics Market, by End User
- 1.4.3 North America Point of Care Molecular Diagnostics Market, by Technology
- 1.4.4 North America Point of Care Molecular Diagnostics Market, by Application
- 1.4.5 North America Point of Care Molecular Diagnostics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- Chapter 4. North America Point of Care Molecular Diagnostics Market by Product & Service
- 4.1 North America Assays & Kits Market by Country
- 4.2 North America Instruments & Analyzers Market by Country
- 4.3 North America Software & Services Market by Country
- Chapter 5. North America Point of Care Molecular Diagnostics Market by End User
- 5.1 North America Physicians Offices Market by Country
- 5.2 North America Hospitals & ICUs Market by Country
- 5.3 North America Research Institutes Market by Country
- 5.4 North America Others Market by Country
- Chapter 6. North America Point of Care Molecular Diagnostics Market by Technology
- 6.1 North America RT-PCR Market by Country
- 6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
- 6.3 North America Others Market by Country
- Chapter 7. North America Point of Care Molecular Diagnostics Market by Application
- 7.1 North America Respiratory Diseases Market by Country
- 7.2 North America Hospital-acquired Infections Market by Country
- 7.3 North America Sexually Transmitted Diseases Market by Country
- 7.4 North America Cancer Market by Country
- 7.5 North America Hepatitis Market by Country
- 7.6 North America Gastrointestinal Disorders Market by Country
- 7.7 North America Others Market by Country
- Chapter 8. North America Point of Care Molecular Diagnostics Market by Country
- 8.1 US Point of Care Molecular Diagnostics Market
- 8.1.1 US Point of Care Molecular Diagnostics Market by Product & Service
- 8.1.2 US Point of Care Molecular Diagnostics Market by End User
- 8.1.3 US Point of Care Molecular Diagnostics Market by Technology
- 8.1.4 US Point of Care Molecular Diagnostics Market by Application
- 8.2 Canada Point of Care Molecular Diagnostics Market
- 8.2.1 Canada Point of Care Molecular Diagnostics Market by Product & Service
- 8.2.2 Canada Point of Care Molecular Diagnostics Market by End User
- 8.2.3 Canada Point of Care Molecular Diagnostics Market by Technology
- 8.2.4 Canada Point of Care Molecular Diagnostics Market by Application
- 8.3 Mexico Point of Care Molecular Diagnostics Market
- 8.3.1 Mexico Point of Care Molecular Diagnostics Market by Product & Service
- 8.3.2 Mexico Point of Care Molecular Diagnostics Market by End User
- 8.3.3 Mexico Point of Care Molecular Diagnostics Market by Technology
- 8.3.4 Mexico Point of Care Molecular Diagnostics Market by Application
- 8.4 Rest of North America Point of Care Molecular Diagnostics Market
- 8.4.1 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service
- 8.4.2 Rest of North America Point of Care Molecular Diagnostics Market by End User
- 8.4.3 Rest of North America Point of Care Molecular Diagnostics Market by Technology
- 8.4.4 Rest of North America Point of Care Molecular Diagnostics Market by Application
- Chapter 9. Company Profiles
- 9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 SWOT Analysis
- 9.2 Bayer AG
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
- 9.3 Thermo Fisher Scientific, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
- 9.4 F. Hoffmann-La Roche Ltd.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.5.3 Acquisition and Mergers:
- 9.5 BioMerieux S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Acquisition and Mergers:
- 9.6 Qiagen N.V.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.7 Danaher Corporation
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.8 Bio-Rad laboratories, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Acquisition and Mergers:
- 9.9 Agilent Technologies, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.10. Nova Biomedical Corporation
- 9.10.1 Company Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook